Express Pharma

MAY 3, 2023

Indoco Remedies announced the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for their facility for solid dosages (Plant I) located in Verna, Goa.

Dosage 84

Dosage Generic Medicine 84

Quality Matters

JUNE 12, 2023

Complex generics: The need and challenges Generic medicines have benefited millions of Americans and saved trillions of dollars. Accounting for approximately 90% of prescriptions filled in the United States , generic medicines are essential to increasing patient access to important drug therapies.

Generic Medicine 52

Generic Medicine Dosage Prescription Filling Diabetes 52

Express Pharma

AUGUST 30, 2023

Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding generic medicines, beckons for clarity.

Generic Medicine 95

Generic Medicine Dosage Compounding Pharmaceutical Companies 95

pharmaphorum

DECEMBER 15, 2020

The generics medicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in. Delivery of essential medicines. Many generic medicines are used in intensive care units globally, while others are used to treat chronic illnesses that do not go away irrespective of the pandemic.

Generic Medicine 93

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Vaccines 93

Quality Matters

JUNE 26, 2023

Complex generics: Are global regulators addressing the needs? The development of generic versions of innovator medicines is a global public health need. 1 Although CGx can add to development complexities, global regulators and standard-setting organizations can help address related challenges.

Dosage 52

Dosage Generic Medicine Labelling 52

Pharma in Brief

JUNE 21, 2020

The revised Draft Guidelines divide existing patented medicines, e. All existing patented medicines are assigned a Maximum List Price ( MLP ) tested against ex-factory list prices. Medicines falling below these thresholds, as well as biosimilars and generics, will be classified as Category II.

Biosimilars 40

Biosimilars Generic Medicine Dosage Documentation 40